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acterial infections following inﬂuenza (Invited Pre-
entation)
4.001
econdary bacterial infections - The other side of
nﬂuenza pathogenesis
. McCullers
St. Jude Children’s Research Hospital, Memphis, TN, USA
Secondary bacterial infections are a major cause of mor-
idity and mortality following inﬂuenza. This was especially
rue during past pandemics, where 50-95% of all deaths were
omplicated by or attributed to bacterial pathogens. The
mergence in 2009 of a new pandemic strain has increased
he urgency for us to understand how bacteria work together
ith inﬂuenza viruses to cause pneumonia. Several mecha-
isms have been postulated to explain this interaction. The
iral neuraminidase has been shown to enhance adherence
f bacteria and increase the incidence of bacterial pneu-
onia. The lack of glycosylation of the surface proteins of
iruses emerging from the avian reservoir contributes to
oth primary virulence and secondary bacterial infections
y preventing viral clearance. Recent work has implicated
he inﬂuenza A virus protein PB1-F2 as a virulence factor
hich enhances secondary bacterial pneumonia. Although
he novel H1N1 swine-origin inﬂuenza virus has molecular
ignatures that predict viral virulence in humans including
igh neuraminidase activity and low glycosyltation, it does
ot possess a functional PB1-F2 protein. In the context of a
andemic, it is likely that secondary bacterial complications
nd overall mortality will be lower because of this absence.
owever, reassortment or mutation to restore PB1-F2 func-
ion to this virus could herald greatly expanded virulence.
oi:10.1016/j.ijid.2010.02.1890
4.002
he role of mucosal antiviral immunity in bacterial sec-
ndary lung infections
. Metzger
Albany Medical College, Albany, NY, USA
Bacterial co-infections are typically a major cause of
ortality following inﬂuenza infection, including infection
ith the pandemic H1N1 Cal/04/09 virus, but the reason
or this increased susceptibility is only poorly understood.
e have found that alveolar macrophages are the ﬁrst
ine of defense against pulmonary pneumococcal and MRSA
nfection, and can very rapidly (within 4 hr) clear almost
ll bacteria after in vivo challenge with a relatively low
ose (up to 105 CFU of pneumococci). However, prior
nﬂuenza virus infection inhibits this clearance mechanism
nd causes normally sublethal doses of bacteria to be 100%
ethal. This is due to production of interferon (IFN)-gamma
uring pulmonary T cell responses to inﬂuenza infection,
hich inhibits scavenger receptor expression by alveolar
acrophages and in turn, leads to decreased bacterial clear-
nce from the lung. Thus, the increased anti-viral immune
esponse causes decreased protection against pulmonary
acterial infection. These results and the potential of vac-
t
1
i
lternational Congress on Infectious Diseases (ICID) Abstracts
ination to induce protection against secondary bacterial
nfections will be discussed in the context of both seasonal
nd H1N1 inﬂuenza infection.
oi:10.1016/j.ijid.2010.02.1891
4.003
lteration of the Innate Immune Rheostat and Suscepti-
ility to Secondary Bacterial Superinfections
. Hussell
National Heart and Lung Institute, London, United Kingdom
Infection of mucosal surfaces culminates in long term
odiﬁcations that impact on future inﬂammatory events.
hese modiﬁcations do not necessarily depend on per-
istence of the original pathogen but on the altered
icroenvironment which occurs upon resolution. This
‘imprinting’’ by the ﬁrst pathogen involves subtle alter-
tions of epithelial cells, resident mucosal macrophages,
roduction of mediators that recruit immune cells and
mportantly, an alteration in the local microbial commensal
ommunity.
Bacterial super-infections are common following
nﬂuenza and lead to a worse prognosis often resulting
n death. Analysis of post-mortem specimens from the
918-19 pandemic shows a bacterial prevalence greater
han 95%. Control of initial bacterial growth relies on
ultiple components of innate immunity, many of which
re disrupted following inﬂuenza virus infection in murine
odels. One key determinant that limits bacterial growth
s the responsiveness of airway macrophages to bacteria in
he airspaces. We show that inﬂuenza virus limits respon-
iveness by enhancing an innate immune negative regulator
CD200 receptor) during resolution of adaptive immunity.
emoval of this single receptor limits bacterial burden in
he airway and lung and completely prevents peripheral
issemination, sepsis and mortality. Adjustment of innate
eactivity may therefore provide a novel opportunity to
revent life-threatening consequences of lung inﬂuenza
irus infection.
oi:10.1016/j.ijid.2010.02.1892
4.004
essons from 1918 and the current H1N1 pandemic on the
ole of bacterial infections during pandemic inﬂuenza
. Klugman
Emory University, Atlanta, GA, USA
The current pandemic of H1N1 inﬂuenza has features
eminiscent of 1918 including infections and excess morbid-
ty in young adults. The impact in terms of mortality has
owever been far less severe. This is in part due to lesser
irulence of the virus, but also to the introduction of antibi-
tics and most recently to the introduction of conjugate
neumococcal vaccines in some countries that have reduced
he morbidity of inﬂuenza associated pneumonia. During the
918 pandemic, post mortem data suggest that the major-
ty of deaths were associated with bacterial superinfection
eading to pneumonia following 4 - 6 days after inﬂuenza. A
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great opportunity for advising and providing health educa-
tion for main risks and preparing passengers for a healthy
and safety itinerary.14th International Congress on Infectious Diseases (ICID) Abs
re - analysis of contemporary blood culture ﬁndings suggest
that most of these infections were pneumococcal, followed
by hemolytic (probably Group A) streptococcal infections,
and a minority of infections were due to Staphylococcus
aureus. Attempts were made at that time to reduce infec-
tion and mortality by killed bacterial vaccines. These trials
were poorly controlled, but an analysis restricted to the
prevention of pneumonia and mortality among inﬂuenza
patients who received these vaccines, suggests that vac-
cines against hemolytic streptococci and pneumococci, but
not Haemophilus inﬂuenzae, may have had some protec-
tion against pneumonia and death. In a randomised trial of
9 valent conjugate pneumococcal vaccine in children who
subsequently developed seasonal inﬂuenza in 1998 - 2000,
hospitalization for pneumonia was reduced by 45%. In the
current pandemic, postmortem data suggest that staphy-
lococcal infections are more common than in 1918, but
pneumococcal infections remain predominant. Where con-
jugate pneumococcal vaccination of children has led to herd
immunity, vaccine serotypes have been largely absent as a
cause of fatal pneumonias. The great majority of individuals
hospitalized with H1N1 pneumonia have received antibiotics
and it is probable that widespread availability of antibiotics
has contributed to the reduction in mortality associated with
this pandemic, by reducing bacterial superinfections in sus-
ceptible individuals.
doi:10.1016/j.ijid.2010.02.1893
Travelers to Latin America with special risks (Invited
Presentation)
45.001
High Altitude Itineraries
M. Cabada
University of Texas Medical Branch, Infectious Diseases Divi-
sion, Galveston/TEXAS, Lima, Peru
Several countries in Latin America double their tourist
arrivals in the last 10 years. The Andes Mountains are the
common denominator for most countries in South America.
Many peaks in this mountain range attract mountaineers and
trekkers which may be aware of the risks at high altitude.
Of importance are the Andean cities and tourism attractions
over 2,400 meters above sea level luring millions every year.
Signiﬁcant numbers of travelers to these destinations are
unaware of the health risks of altitude or come unprepared.
The diseases related to high altitude ascend are referred
to as high altitude illnesses (HAI). These comprise acute
mountain sickness (AMS), high altitude cerebral edema
(HACE), and high altitude pulmonary edema (HAPE). AMS
affects 20% to 50% of travelers to altitudes up to 4000
meters. HACE and HAPE are less common affecting 0.01% to
2% of travelers to similar altitudes. The risk factors can be
classiﬁed as intrinsic (not modiﬁable), which include age,
preexisting medical conditions, prior history of HAI, and
probably genetic factors. Modiﬁable risk factors include rate
of ascend, sleeping altitude, altitude attained, degree of
exertion, and medications. The hypoxic ventilatory response
is an individual risk factor that can be suppressed or stimu-
lated.
dts e183
Information is of paramount importance in prevention of
AI. Informed travelers are likely to comply with recom-
endations, recognize symptoms, and avoid complications.
gradual slow ascent, when possible, is as important for
revention. Other non-pharmacological measures are avoid-
ng exertion, dehydration, or use of respiratory suppressing
ubstances. AMS/HACE pharmacologic prevention consists of
cetazolamide or dexamethasone. Nifedipine, tadaﬁl, and
nhaled !-agonists are used for HAPE prevention.
Descent is effective to treat all HAI but is not always
ossible in remote areas or desirable for milder cases.
lternatives like rest, oxygen, medications, positive air-
ay pressure and hyperbarics devices provide support until
escent is possible or acclimatization ensues.
oi:10.1016/j.ijid.2010.02.1894
5.002
isks on Common Cruise Itineraries
. Rísquez Parra
Centro de Vacunaciones, Caracas, Venezuela
Cruise travel has become one of the most popular ways to
isit different places and is increasing in terms of cruise pas-
engers, voyages and region destinations. Most passengers,
oyages and cruises are considered from low to medium
ealth risks. A cruise offers a wide spectrum of services and
s oriented to different customers with clearly different life
tyles risks from children, families up to elderly. Tradition-
lly, about one third of travelers are above 65 years old and
ther adults have some special conditions. However, dur-
ng last few years the number of cruises oriented to young
dults and visiting different regions and very peculiar envi-
onments such as the Amazons may increase the health risk
igniﬁcantly. Although, exposition to a mixture of people
rom different countries and diverse environments visited
end to change usual lifestyle or behaviors in terms of look-
ng for adventures and new activities during vacations. In
erms of travel health risks, the age of the cruise member is
xtremely related to the chance to suffer an event (sickness
r accident) due mainly to underlying chronic health prob-
ems. Most common health problems are associated with
ovement (sea-sickness) and gastrointestinal diseases.
Communicable diseases are easily disseminated because
lot of activities for long hours made in semi-enclosed cab-
ns and many times very crowded. And as in crowded places
nd high interactive communities, cruise passengers are not
n exemption for airborne diseases, as ﬂu infections and
ther acute respiratory illnesses. Injuries account for an
mportant number of inﬁrmary visits. Medical care aboard
s important for preventive and caring passengers and crew
or health and medical issues. Pre-travel consultation is aoi:10.1016/j.ijid.2010.02.1895
